Genomic profiling of intestinal-type sinonasal adenocarcinoma reveals subgroups of patients with distinct clinical outcomes-Reference-Cited by-同舟云学术

Genomic profiling of intestinal-type sinonasal adenocarcinoma reveals subgroups of patients with distinct clinical outcomes

Published:2017-09-30 Issue:2 Volume:40 Page:259-273
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

López-Hernández Alejandro¹,Pérez-Escuredo Jhudit¹,Vivanco Blanca²,García-Inclán Cristina¹,Potes-Ares Sira¹,Cabal Virginia N.¹,Riobello Cristina¹,Costales María¹,López Fernando¹^ORCID,Llorente José Luis¹,Hermsen Mario A.¹^ORCID

Affiliation:

1. Department of Otolaryngology; IUOPA, Hospital Universitario Central de Asturias; Oviedo Asturias Spain

2. Department of Pathology; Hospital Universitario Central de Asturias; Oviedo Spain

Publisher

Wiley

Subject

Otorhinolaryngology

Reference52 articles.

1. European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base;Lund;Rhinol Suppl.,2010

2. Arsenic, metals, fibres, and dusts;IARC Working Group on the Evaluation of Carcinogenic Risks to Humans;IARC Monogr Eval Carcinog Risks Hum.,2012

3. International comparisons of the incidence and mortality of sinonasal cancer;Youlden;Cancer Epidemiol.,2013

4. Sinonasal carcinoma: clinical, pathological and genetic advances for new therapeutic opportunities;Llorente;Nat Rev Clin Oncol.,2014

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary intestinal-type adenocarcinoma: Report of a rare case involving a young patient;Oral Oncology;2024-03

2. Tumor Markers and Their Prognostic Value in Sinonasal ITAC/Non-ITAC;Cancers;2023-06-15

3. Precision Medicine in the Treatment of Malignancies Involving the Ventral Skull Base: Present and Future;Critical Issues in Head and Neck Oncology;2023

4. Neoplasms of the Sinonasal Tract;Atlas of Head and Neck Pathology;2023

5. Personalized Medicine in Skull Base and Sinonasal Tumors;Journal of Personalized Medicine;2022-12-01